ArticleOncotarget2017
Serum CD166: A novel biomarker for predicting nasopharyngeal carcinoma response to radiotherapy.
Huan Lin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this papercites it
ArticleOncotarget2017
Huan Lin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.